Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 10-2024 | 10-2023 | 10-2022 | 10-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 189 | 4,417 | 6,466 | 2,933 | 22,168 |
| Marketable Securities | N/A | N/A | 8,218 | 35,733 | N/A |
| Receivables | 88 | 219 | 781 | 891 | 357 |
| TOTAL | $373 | $4,753 | $15,587 | $39,687 | $22,529 |
| Non-Current Assets | |||||
| PPE Net | 13 | 220 | 292 | 313 | 140 |
| Intangibles | 0 | 0 | 235 | 401 | 570 |
| Other Non-Current Assets | 160 | 557 | 277 | 369 | 477 |
| TOTAL | $173 | $777 | $803 | $1,083 | $1,187 |
| Total Assets | $546 | $5,530 | $16,390 | $40,770 | $23,716 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,040 | 14,631 | 7,011 | 3,574 | 1,080 |
| TOTAL | $17,703 | $14,705 | $7,112 | $3,682 | $1,174 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 745 | 0 | 0 | 0 | 0 |
| TOTAL | $745 | $344 | $N/A | $106 | $220 |
| Total Liabilities | $18,448 | $15,050 | $7,112 | $3,788 | $1,393 |
| Shareholders' Equity | |||||
| Common Shares | 84,738 | 85,725 | 82,286 | 86,215 | 58,861 |
| Retained earnings | -118,581 | -110,469 | -87,609 | -61,499 | -43,542 |
| Other shareholders' equity | 384 | 25 | 0 | 2,561 | 2,937 |
| TOTAL | $-17,902 | $-9,519 | $9,278 | $36,982 | $22,323 |
| Total Liabilities And Equity | $546 | $5,530 | $16,390 | $40,770 | $23,716 |